The CNRGH as the genomic partner in PROPSY

PROPSY, PEPR for Precision Psychiatry, aims to develop research on psychiatric diseases such as bipolarity, depression, schizophrenia and autism spectrum disorder.  The CNRGH, partner of the project for genomic analyses, will thereby participate in a better understanding of these pathologies, in the identification of precise prognostic markers and innovative therapeutic options.